Glenmark Shares hit on loss of Tarka patent appeal

Abbott, which paid $290 million for an exclusive license to Tarka, was seeking $25 million as compensation for profit it lost because of Glenmark's sale of the generic drug.

















from NDTV News - Profit http://ift.tt/1eZseFy